A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

Peking University People's Hospital, Beijing

Beijing Friendship Hospital, Capital Medical University, Beijing

Chinese PLA General Hospital, Beijing

General Hospital of Northern Theater Command, Shenyang

The Second Hospital of Jilin University, Changchun

The Second Hospital of Jilin University, Changchun

Tongji Hospital of Tongji University, Shanghai

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

The Second Hospital of Anhui Medical University, Hefei

LiaoCheng People's Hospital, Liaocheng

The First Affiliated hospital of Xiamen University, Xiamen

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Changsha Central Hospital, Changsha

Xiangya Hospital Central South University, Changsha

The Third Xiangya Hospital of Central South University, Changsha

Renmin Hospital Of Wuhan University, Wuhan

Wuhan Third Hospital, Wuhan

Guangzhou First People's Hospital, Guangzhou

Hainan General Hospital, Haikou

West China Hospital of Sichuan University, Chengdu

The Second Affiliated hospital of Kunming Medical University, Kunming

Shaanxi Provincial People' Hospital, Xi'an

The First Affiliated Hospital of Xi'an Medical University, Xi'an

Yan'an University Xianyang Hospital Co., Ltd, Xianyang

The Second Affiliated Hospital of Xinjiang Medical University, Ürümqi

Hebei General Hospital, Shijiazhuang